# RELISTOR's Effects on Opioid-Induced Constipation

> **NCT04930237** · — · WITHDRAWN · sponsor: **Methodist Health System**

## Conditions studied

- OIC

## Interventions

- **DRUG:** Relistor Injectable Product
- **DRUG:** Docusate Calcium
- **DRUG:** Bisacodyl
- **DRUG:** Milk of magnesia
- **DRUG:** Magnesium citrate
- **DRUG:** Senna
- **DRUG:** Enema

## Key facts

- **NCT ID:** NCT04930237
- **Lead sponsor:** Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-04-22
- **Final completion:** 2022-04-22
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI request to close study
- **Last updated:** 2026-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930237, "RELISTOR's Effects on Opioid-Induced Constipation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04930237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*